Jasper Therapeutics, Inc. - JSPR
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 17, 2026 | SCHEDULE 13G | Velan Capital Master Fund LP | 8.9% | 3,037,776 | View |
| Aug 17, 2026 | SCHEDULE 13G | Velan Capital Holdings LLC | 8.9% | 3,037,776 | View |
| Aug 17, 2026 | SCHEDULE 13G | Velan Horizon Fund LP | 0.2% | 82,008 | View |
| Aug 17, 2026 | SCHEDULE 13G | Velan Horizon GP LLC | 0.2% | 82,008 | View |
| Aug 17, 2026 | SCHEDULE 13G | Avego Healthcare Capital, L.P. | 0.7% | 243,563 | View |
| Aug 17, 2026 | SCHEDULE 13G | Avego Healthcare Capital Holdings, LLC | 0.7% | 243,563 | View |
| Aug 17, 2026 | SCHEDULE 13G | Avego Management LLC | 0.7% | 243,563 | View |
| Aug 17, 2026 | SCHEDULE 13G | Velan Capital Investment Management LP | 9.9% | 3,363,347 | View |
| Aug 17, 2026 | SCHEDULE 13G | Velan Capital Management LLC | 9.9% | 3,363,347 | View |
| Aug 17, 2026 | SCHEDULE 13G | Morgan Adam | 9.9% | 3,363,347 | View |
| Aug 17, 2026 | SCHEDULE 13G | VENKATARAMAN BALAJI | 9.9% | 3,363,347 | View |
| Aug 17, 2026 | SCHEDULE 13G | Kapoor Vishal | 0.1% | 35,013 | View |
| Jul 20, 2026 | SCHEDULE 13D/A | — | 9.99% | 23,133,322 | View |
| Jul 10, 2026 | SCHEDULE 13G/A | Integrated Core Strategies (US) LLC | 1.7% | 486,454 | View |
| Jul 10, 2026 | SCHEDULE 13G/A | Millennium Management LLC | 1.7% | 486,933 | View |
| Jul 10, 2026 | SCHEDULE 13G/A | Millennium Group Management LLC | 1.7% | 486,933 | View |
| Jul 10, 2026 | SCHEDULE 13G/A | Israel A. Englander | 1.7% | 486,933 | View |
| May 08, 2026 | SCHEDULE 13G/A | Soleus Capital Master Fund, L.P. | 0.4% | 118,912 | View |
| May 08, 2026 | SCHEDULE 13G/A | Soleus Private Equity Fund III, L.P. | 0.6% | 157,400 | View |
| May 08, 2026 | SCHEDULE 13G/A | Soleus Private Equity GP III, LLC | 0.6% | 157,400 | View |
| May 08, 2026 | SCHEDULE 13G/A | Soleus PE GP III, LLC | 0.6% | 157,400 | View |
| May 08, 2026 | SCHEDULE 13G/A | Soleus Capital, LLC | 0.4% | 118,912 | View |
| May 08, 2026 | SCHEDULE 13G/A | Soleus Capital Group, LLC | 0.4% | 118,912 | View |
| May 08, 2026 | SCHEDULE 13G/A | Soleus Capital Management, L.P. | 1.0% | 276,312 | View |
| May 08, 2026 | SCHEDULE 13G/A | Soleus GP, LLC | 1.0% | 276,312 | View |
| May 08, 2026 | SCHEDULE 13G/A | Guy Levy | 1.0% | 276,312 | View |
| May 08, 2026 | SCHEDULE 13G/A | THE GOLDMAN SACHS GROUP, INC. | 0.5% | 128,862 | View |
| May 08, 2026 | SCHEDULE 13G/A | GOLDMAN SACHS & CO. LLC | 0.5% | 128,862 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.